Squarepoint Ops LLC Precision Biosciences Inc Transaction History

Squarepoint Ops LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $26,529 - $77,050	-23,069 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.96 - $7.76 $1,349 - $3,538	456 Added 2.02%	23,069 $71,000
Q4 2021 Feb 14, 2022	BUY	$7.4 - $11.66 $89,636 - $141,237	12,113 Added 115.36%	22,613 $167,000
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $96,390 - $148,575	10,500 New	10,500 $121,000
Q1 2021 May 17, 2021	SELL	$8.57 - $15.79 $542,001 - $998,622	-63,244 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.98 - $12.47 $94,824 - $197,736	15,857 Added 33.46%	63,244 $527,000
Q3 2020 Nov 16, 2020	BUY	$4.65 - $8.73 $220,349 - $413,688	47,387 New	47,387 $292,000
Q2 2020 Aug 14, 2020	SELL	$4.66 - $8.7 $88,358 - $164,960	-18,961 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.05 - $15.01 $339,718 - $1.01 Million	-67,271 Reduced 78.01%	18,961 $114,000
Q4 2019 Feb 14, 2020	BUY	$6.32 - $19.66 $280,696 - $873,179	44,414 Added 106.21%	86,232 $1.2 Million
Q3 2019 Nov 14, 2019	BUY	$8.03 - $14.82 $335,798 - $619,742	41,818 New	41,818 $351,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $744M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.